ORIONINFU Stock Overview
Engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Orion Infusion Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳538.10 |
| 52 Week High | ৳726.90 |
| 52 Week Low | ৳284.20 |
| Beta | -1.82 |
| 11 Month Change | 14.17% |
| 3 Month Change | -12.03% |
| 1 Year Change | 49.06% |
| 33 Year Change | 666.52% |
| 5 Year Change | 751.42% |
| Change since IPO | 4,384.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| ORIONINFU | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -3.0% | -0.5% | -0.5% |
| 1Y | 49.1% | -18.2% | -20.4% |
Return vs Industry: ORIONINFU exceeded the BD Pharmaceuticals industry which returned -19.5% over the past year.
Return vs Market: ORIONINFU exceeded the BD Market which returned -21.5% over the past year.
Price Volatility
| ORIONINFU volatility | |
|---|---|
| ORIONINFU Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in BD Market | 7.4% |
| 10% least volatile stocks in BD Market | 3.6% |
Stable Share Price: ORIONINFU's share price has been volatile over the past 3 months.
Volatility Over Time: ORIONINFU's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 764 | Salman Karim | www.orioninfusion.com |
Orion Infusion Limited engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh. It offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; Metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd.
Orion Infusion Limited Fundamentals Summary
| ORIONINFU fundamental statistics | |
|---|---|
| Market cap | ৳10.96b |
| Earnings (TTM) | ৳42.70m |
| Revenue (TTM) | ৳850.39m |
256.5x
P/E Ratio12.9x
P/S RatioIs ORIONINFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORIONINFU income statement (TTM) | |
|---|---|
| Revenue | ৳850.39m |
| Cost of Revenue | ৳508.52m |
| Gross Profit | ৳341.87m |
| Other Expenses | ৳299.17m |
| Earnings | ৳42.70m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.10 |
| Gross Margin | 40.20% |
| Net Profit Margin | 5.02% |
| Debt/Equity Ratio | 93.9% |
How did ORIONINFU perform over the long term?
See historical performance and comparison